Gestational Diabetes Screening and Management at 24 Weeks of Pregnancy
Gestational Diabetes Screening
- The USPSTF strongly recommends screening for gestational diabetes mellitus (GDM) in asymptomatic pregnant women after 24 weeks of gestation, with a B recommendation 2, 3, 4
- The American College of Physicians recommends that all pregnant women be screened for GDM at 24-28 weeks of gestation, as stated in the Annals of Internal Medicine 1, 2, 3
- The most common screening approach in the United States is the 2-step method, which includes an initial 50-g oral glucose challenge test (OGCT) in a non-fasting state, followed by an oral glucose tolerance test (OGTT) if the screening threshold is met or exceeded 5
- Early detection and treatment of GDM significantly reduces the risk for preeclampsia, fetal macrosomia, and shoulder dystocia, with a strong evidence base 2, 3
Risk Factors for GDM
- Women at higher risk for GDM include those who are obese, older than 25 years, have a family history of diabetes, have a history of previous gestational diabetes, or belong to certain ethnic groups (Hispanic, Native American, South or East Asian, African American, or Pacific Island descent) 5, 6
Additional Laboratory Tests
- Consider checking hemoglobin/hematocrit to assess for anemia in pregnant women, as recommended by the Obesity Reviews 7
- For women who have had bariatric surgery, additional monitoring is recommended, including full blood count, serum ferritin, and iron studies, as well as serum folate and vitamin B12, serum vitamin A, and vitamin E assessment 7
Potential Pitfalls and Caveats
- False positive results from GDM screening can cause unnecessary anxiety and inconvenience, highlighting the need for careful interpretation of screening results 6
- The 50-g OGCT has variable sensitivity and specificity depending on the threshold used, which should be taken into account when interpreting screening results 5
- There is insufficient evidence to recommend universal screening for GDM before 24 weeks of gestation, as stated in the Annals of Internal Medicine (I statement) 2, 4, 8
Follow-up Care
- For women diagnosed with GDM, management includes dietary modifications, moderate physical activity, glucose monitoring, support from diabetes educators and nutritionists, and medication (insulin or oral hypoglycemic agents) if glucose is not controlled with lifestyle interventions, as recommended by the Annals of Internal Medicine 5, 6